ELYM: Eliem Therapeutics Company Short-Term Debt
The short-term liabilities chart for Eliem Therapeutics (ELYM) demonstrates the financial standing under full R&D laboratory capacity and flawless equipment operation, where the indicator stands at 0.00. The business relies on the development of small molecules for the therapy of pain and epilepsy. High authority within the scientific community confirms its status as an innovator developing anti-inflammatory agents to update medical standards.
Metric breakdowns and analytics for Eliem Therapeutics, Inc. (ELYM)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity details:
Total Debt to Capital Eliem Therapeutics|ELYM - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital Eliem|ELYM - Company Cumulative Debt|Debt to Book Capitalization Ratio Eliem Therapeutics Inc.|ELYM - Company Long-Term Liabilities|Company Current Liabilities Eliem Therapeutics|Quick Liquidity Indicator eliemtx.com
- net income and valuation multiples indicators:
Basic company analysis:ELYM - eliemtx.com
For Eliem Therapeutics (ELYM), which is establishing long-term patent monopolies in pain therapy, controlling short-term liabilities is critical for maintaining operational autonomy until drug commercialization. By analyzing the current volume of short-term loans, an investor assesses the amount of debt maturing within one year, where stable dynamics confirm solvency, while sharp spikes signal a risk of liquidity shortages.
Competitor analysis
BIIB - Company Short-Term Debt|Company Short-Term Loans and Borrowings NBIX (Neurocrine)|Regencell (RGC) - Company Short-Term Debt|Short-Term Debt Axsome Corp (AXSM)|ACAD (ACADIA Pharmaceuticals) - Company Short-Term Debts|Short-Term Debt xenon-pharma.com XENE|Company Short-Term Debt Viking Therapeutics, Inc. (VKTX)|Company Short-Term Debt SUPN (Supernus Pharmaceuticals, Inc.)|Company Short-Term Debts CPRX (Catalyst Pharmaceuticals Inc)|Short-Term Debt Volume Denali Corp (DNLI)|Harmony Biosciences - Company Short-Term Debts|Short-Term Debt biohavenpharma.com|Amylyx Pharmaceuticals, Inc. (AMLX) - Company Short-Term Debt|Company Current Liabilities Trevi Therapeutics Inc|Company Current Liabilities PRAX|AVXL: Company Short-Term Loans and Borrowings|Company Current Liabilities CBLL (CeriBell, Inc.)|Amount of Current Liabilities PRTA|Company Short-Term Debts ALEC (Alector)|Company Short-Term Loans and Borrowings ANNX|Omeros Corp. - Company Short-Term Debts|Short-Term Debt Neurogene Therapeutics|AC Immune (ACIU) - Company Short-Term Debt|voyagertherapeutics.com - Company Short-Term Loans and Borrowings|NMRA (Neumora Therapeutics, Inc.) - Company Short-Term Debts|Company Short-Term Debts Scilex Holding|Company Short-Term Debt Tevogen Bio Holdings, Inc. (TVGN)|ACOG: Current Liabilities|Company Short-Term Debts CGTX (Cognition Therapeutics, Inc.)|inhibikase.com (IKT) - Short-Term Debt|SAVA: Company Current Liabilities|ASRT - Company Short-Term Debts|COYA (coyatherapeutics.com) - Company Current Liabilities|VTGN: Amount of Current Liabilities|OVID (Ovid Therapeutics Inc) - Company Short-Term Debts|acumenpharm.com (ABOS) - Short-Term Debt Volume|Company Short-Term Debts CRVO|Company Current Liabilities alteritytherapeutics.com ATHE|Company Short-Term Debt Clene CLNN|Short-Term Debt Volume PepGen Inc (PEPG)|Jupiter Neurosciences - Company Short-Term Debts|Short-Term Debt relmada.com|Annovis Bio (ANVS) - Company Short-Term Debt|GRCE (Grace Therapeutics) - Company Short-Term Debt|Company Current Liabilities AIFF|Short-Term Debt ANEW Medical, Inc. KLTO|Company Short-Term Debt NeuroSense Therapeutics (NRSN)|Company Current Liabilities revivapharma.com RVPH|Company Short-Term Debt MetaVia MTVA|NRXS: Company Short-Term Indebtedness|Helius Medical Technologies Inc. - Company Short-Term Debts|Short-Term Debt Passage Bio, Inc.|NEUP (bionomics.com.au) - Company Current Liabilities|minervaneurosciences.com (NERV) - Company Short-Term Debts|Company Short-Term Debt Athira Pharma|ADXN: Company Short-Term Loans and Borrowings|Company Short-Term Debt Alzamend Neuro, Inc. (ALZN)|CYCN - Short-Term Debt|Company Short-Term Debts PTIX (Protagenic Therapeutics, Inc.)|Pasithea Therapeutics Corp (KTTA) - Short-Term Debt|CRGT - Company Short-Term Debt|ATXI: Company Short-Term Debt|BCLI: Company Short-Term Debts|CARA - Short-Term Debt Volume|CHRO (Chromocell Therapeutics) - Company Short-Term Debts|Short-Term Debt Intra-Cellular ITCI|Company Short-Term Debt Longboard Pharmaceuticals, Inc. (LBPH)|Company Current Liabilities Marinus Pharmaceuticals Inc MRNS|NKGen - Company Current Liabilities|Company Short-Term Loans and Borrowings NRBO|SAGE: Company Current Liabilities|synaptogen.com - Amount of Current Liabilities|TRVN: Company Short-Term Debts|Vigil Neuroscience, Inc. - Company Short-Term Loans and Borrowings|WENA (Anew Medical, Inc.) - Company Short-Term Debts|Short-Term Debt Cerevel Corp CERE